Vir Biotechnology Competitors and Similar CompaniesClear all

Vir Biotechnology's competitors and similar companies include AlloVir, Novan, Imaxio and Laverock Therapeutics.
Vir Biotechnology
Vir Biotechnology
Vir Biotechnology is a clinical-stage immunology company focused on finding solutions to treat and prevent serious infectious diseases.
AlloVir
AlloVir
AlloVir (formerly known as ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases.
Novan
Novan
Novan is a clinical-stage biotechnology company focused on treating dermatological and oncovirus-mediated diseases.
Imaxio
Imaxio
Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis.
Laverock Therapeutics
Laverock Therapeutics
Laverock Therapeutics is a company that provides genome editing solutions.
Founding Date
Founding Date
2016
Founding Date
2013
Founding Date
2008
Founding Date
2000
Founding Date
2021
Type
Type
Public
Type
Public
Type
Private
Type
Private
Type
Private
Tags
Locations
Locations
San Francisco, US HQ
Bellinzona, CH
Cambridge, US
Portland, US
Locations
Waltham, US HQ
Milan, IT
Houston, US
Waltham, US
Locations
US HQ
Durham, US
Locations
Paris, FR HQ
Lyon, FR
Locations
Stevenage, GB HQ
Employees
Employees
2175% increase
Employees
1126% increase
Employees
442% decrease
Employees
244% increase
Employees
29
Valuation ($)
Valuation ($)
1.1 b
Valuation ($)
88.1 m
Valuation ($)
N/A
Valuation ($)
N/A
Valuation ($)
N/A
Twitter followers
Twitter followers
3.4 k
Twitter followers
311
Twitter followers
3.2 k
Twitter followers
N/A
Twitter followers
N/A
Number of tweets (last 30 days)
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
3
Number of tweets (last 30 days)
6
Number of tweets (last 30 days)
N/A
Number of tweets (last 30 days)
N/A
Average likes per tweet (last 30 days)
Average likes per tweet (last 30 days)
2.3
Average likes per tweet (last 30 days)
1.7
Average likes per tweet (last 30 days)
9.3
Average likes per tweet (last 30 days)
N/A
Average likes per tweet (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
33.33%
Percentage of tweets with engagement (last 30 days)
100%
Percentage of tweets with engagement (last 30 days)
N/A
Percentage of tweets with engagement (last 30 days)
N/A

Financial

Net income
Net income
($615.1m) (FY, 2023)
Net income
($190.4m) (FY, 2023)
Net income
N/A
Net income
N/A
Net income
N/A

Operating

Patents (US)
Patents (US)
1 (Oct, 2019)
Patents (US)
2 (Jul, 2020)
Patents (US)
N/A
Patents (US)
N/A
Patents (US)
N/A

Funding

Total funding raised
Total funding raised
$ 637.7m
Total funding raised
$ 159m
Total funding raised
N/A
Total funding raised
$ 3.8m
Total funding raised
$ 16.4m
For sources of this data, please see the company profile

View Company Profiles

AlloVir
HQ
Waltham, US
Employees
112↑ 6% increase

AlloVir (formerly known as ViraCyte) is a company that develops and delivers transformative cell therapies for patients suffering from life-threatening virus-associated diseases.

View company
Novan
HQ
US
Employees
44↓ 2% decrease

Novan is a clinical-stage biotechnology company focused on treating dermatological and oncovirus-mediated diseases.

View company
Imaxio
HQ
Paris, FR
Employees
24↑ 4% increase

Imaxio is a biotech company specializing in vaccinology and in human leptospirosis prophylaxis.

View company
Laverock Therapeutics
HQ
Stevenage, GB
Employees
29

Laverock Therapeutics is a company that provides genome editing solutions.

View company